Heart Test Laboratories I...

NASDAQ: HSCS · Real-Time Price · USD
3.85
-0.02 (-0.39%)
At close: May 23, 2025, 10:58 AM

Heart Test Laboratories Statistics

Share Statistics

Heart Test Laboratories has 1.08M shares outstanding. The number of shares has increased by 64.87% in one year.

Shares Outstanding 1.08M
Shares Change (YoY) 64.87%
Shares Change (QoQ) 10.26%
Owned by Institutions (%) 2.89%
Shares Floating n/a
Failed to Deliver (FTD) Shares 246
FTD / Avg. Volume 1.67%

Short Selling Information

The latest short interest is 9.04K, so 0.84% of the outstanding shares have been sold short.

Short Interest 9.04K
Short % of Shares Out 0.84%
Short % of Float 0.84%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is -0.49 and the forward PE ratio is -0.53. Heart Test Laboratories's PEG ratio is 0.

PE Ratio -0.49
Forward PE -0.53
PS Ratio 175.12
Forward PS 0.7
PB Ratio 0.45
P/FCF Ratio -0.53
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Heart Test Laboratories.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.2, with a Debt / Equity ratio of 0.14.

Current Ratio 4.2
Quick Ratio 3.84
Debt / Equity 0.14
Debt / EBITDA -0.17
Debt / FCF -0.17
Interest Coverage -17.81

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $1,240
Profits Per Employee $-440,347.2
Employee Count 15
Asset Turnover 0
Inventory Turnover 0.01

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -30.74% in the last 52 weeks. The beta is 2.63, so Heart Test Laboratories's price volatility has been higher than the market average.

Beta 2.63
52-Week Price Change -30.74%
50-Day Moving Average 3.24
200-Day Moving Average 3.38
Relative Strength Index (RSI) 58.38
Average Volume (20 Days) 14,745

Income Statement

In the last 12 months, Heart Test Laboratories had revenue of 18.6K and earned -6.61M in profits. Earnings per share was -18.74.

Revenue 18.6K
Gross Profit 12.52K
Operating Income -6.31M
Net Income -6.61M
EBITDA -6.16M
EBIT -6.25M
Earnings Per Share (EPS) -18.74
Full Income Statement

Balance Sheet

The company has 5.81M in cash and 1.04M in debt, giving a net cash position of 4.77M.

Cash & Cash Equivalents 5.81M
Total Debt 1.04M
Net Cash 4.77M
Retained Earnings -67.36M
Total Assets 5.7M
Working Capital -77.64K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.07M and capital expenditures -125.27K, giving a free cash flow of -6.2M.

Operating Cash Flow -6.07M
Capital Expenditures -125.27K
Free Cash Flow -6.2M
FCF Per Share -17.57
Full Cash Flow Statement

Margins

Gross margin is 67.31%, with operating and profit margins of -33901.99% and -35511.87%.

Gross Margin 67.31%
Operating Margin -33901.99%
Pretax Margin -35511.87%
Profit Margin -35511.87%
EBITDA Margin -33096.75%
EBIT Margin -33901.99%
FCF Margin -33308.9%

Dividends & Yields

HSCS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for HSCS is $14, which is 265.5% higher than the current price. The consensus rating is "Buy".

Price Target $14
Price Target Difference 265.5%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on May 17, 2024. It was a backward split with a ratio of 1:100.

Last Split Date May 17, 2024
Split Type backward
Split Ratio 1:100

Scores

Altman Z-Score -19546.22
Piotroski F-Score 0